HCD Economics

11/10/2022

A pleasure as always!

24/01/2022

https://www.hcdeconomics.com/news/latest-news/prime-global-acquires-hcd-economics/

Prime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group

08/01/2021

A study on the 'Burden of Illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany' is now underway. We hope this study will give patients a much-needed voice once it is completed.
https://www.tandfonline.com/doi/full/10.1080/14737167.2021.1859371

09/12/2020

Duchenne UK and the Project HERCULES team held a webinar to celebrate all of the achievements through this ground breaking collaboration to speed up access to treatments.
Thank you for organising this fantastic webinar!

The webinar included presentations from all those involved in the outputs of Project HERCULES Phase 1 including our own Jamie O'Hara

You can watch the recording here:
https://lnkd.in/dCFTDi3

Duchenne UK and the Project HERCULES team held a webinar to celebrate all of our achievements through this ground breaking collaboration to speed up access to treatments.

08/12/2020

ISPOR extends on-line event during December, HCD award winning research available now check out more below and links to our posters!

The live Virtual ISPOR Europe 2020 was held 16 – 19 November. The event brought together a vibrant community of experts and thought leaders virtually to help shape the future of HEOR. ISPOR states ‘we looked at fundamental conventions around value, risk, rewards, and the role of public and priva...

26/11/2020

25/11/2020

Next up from our posters our poster on also received an award with average review scores in the top 10% . Quantifying the Socio-economic burden of Huntington's disease in the US and EU5: Study Design and Statistical Analysis Details

https://europe2020-ispor.ipostersessions.com/Default.aspx?s=41-D8-73-9B-19-0C-E3-FF-B4-6D-01-87-A2-E8-6C-BC

Thank you to all our partners for your ongoing support Huntington's Disease Association Huntington's Disease Society of America HDYO (Huntington's Disease Youth Organisation) European Huntington Association Lega Italiana Ricerca Huntington-LIRH onlus

Supported by uniQure

•The overall prevalence of Huntington’s Disease (HD) is increasing [1], and the burden associated with this condition is substantial [2-3]. However, limited evidence is available on the comprehensive assessment of clinical, economic, and humanistic burden of HD from a multinational perspective.

24/11/2020

We really enjoyed last week, we presented 9 posters across the areas of, , , and . 2 of our posters received GOLD awards, with average review scores in the top 10% .
First up our poster with uniQure on A Discrete-Choice Experiment with Duration to Compare the Preferences of People with Haemophilia and the General Population
Click the link below to view the full poster
https://lnkd.in/en7c7J4

You can keep on working with your poster. Any changes you make will be updated on the iPoster directly. You don't need to publish your poster again.

20/11/2020

Thank you to everyone who attended our NASH webinar and to our fantastic speakers! Please see further information on the webinar and the link to the recording below. Professors Manuel Romero Gomez and Prof. Dr. Jörn M. Schattenberg, leading experts in liver disease and members of the HCD Economics Expert Reference Group for the GAIN study (Global Assessment of the Impact of NASH (Non-Alcoholic SteatoHepatitis), a socio-economic study), addressed a global audience of over 30 delegates in a webinar intended to share the design and results of the GAIN study (published in 2020 in JHEP Reports the companion Journal to the highly respected Journal of Hepatology) and provide a forum for a live Q and A session, open to all webinar delegates.
This study is in partnership with the University of Chester
and British Liver Trust

https://lnkd.in/emR4u3b

Professors Manuel Romero Gómez and Jörn M. Schattenberg, leading experts in liver disease and members of the HCD Economics Expert Reference Group for the GAIN study (Global Assessment of the Impact of NASH (Non-Alcoholic SteatoHepatitis), a socio-economic study), addressed a global audience of ove...

18/11/2020

JOIN OUR WEBINAR TOMORROW, LAST FEW PLACES AVAILABLE! Register here https://lnkd.in/duUZksg The Cost of Non-Alcoholic Steatohepatitis (NASH) in Europe and USA: THE GAIN STUDY. Dr.Jörn Schattenberg and Prof Manuel Romero-Gómez eminent key opinion leaders in NASH and key members of HCD’s GAIN Study expert reference group, will be conducting a webinar focused on the GAIN study results based on the recently published GAIN study manuscript in JHEP Reports (official journal of EASL).
This study is in partnership with the University of Chester and British Liver Trust

17/11/2020

We are very pleased to be presenting a number of posters at this week, we will be sharing them with you throughout the next week. First up this cost effectiveness analysis of Impella for haemodynamic support during high risk percutaneous coronary interventions. Click on the link below to read the full poster.
Please contact lesley.piltz@hcdeconomics.com for any further information
https://lnkd.in/e4828fP

16/11/2020

We are excited to invite you to our webinar, Nov 19, at 2pm GMT on The Cost of Non-Alcoholic Steatohepatitis (NASH) in Europe and USA: THE GAIN STUDY. Please click on the link to register and secure your spot! https://lnkd.in/duUZksg
Dr.Jörn Schattenberg and Prof Manuel Romero-Gómez eminent key opinion leaders in NASH and key members of HCD’s GAIN Study expert reference group, will be conducting a webinar focused on the GAIN study results based on the recently published GAIN study manuscript in JHEP Reports (official journal of EASL).
This study is in partnership with the University of Chester and The British Liver Trust